Leonardo DRS: Mark Dorfman sells EUR 237,930 while defense peers stay bid

Leonardo DRS, Inc. makes money in the part of defense that has become the market’s favorite excuse for paying up, and for once the excuse is not flimsy. The company sits in defense electronics and sensing, with exposure to tactical radars, infrared sensing, electric power and propulsion, and naval systems. Those are the kinds of programs that benefit when governments keep spending on sensors, autonomy, space, and the industrial base needed to build all of it at scale.

That matters because the sector backdrop is still doing the work. PwC says aerospace and defense passed $1 trillion in annual revenue for the first time in 2025, while defense backlogs have grown more than 50% over three years. Reuters reported in July that Lockheed Martin lifted its 2026 sales and profit forecasts, with backlog at $230.4 billion. DRS is not Lockheed, and it does not need to be. It sells into the same broad budget cycle, and that cycle remains generous.

InsiderTrades data shows a historical T+90 cohort return of +3.25% and a 55.6% win rate for director-level buys at large-cap names, across 5,370 cases. That is a useful reference point, not a promise. The bucket is not this filing, and the market does not owe you a repeat.

The business is still growing faster than the stock has lately

DRS reported Q2 2026 revenue of $913 million, up 10% organically, with adjusted EBITDA up 33%. Management raised full-year guidance to revenue of $3.9 billion to $3.975 billion, adjusted EBITDA of $525 million to $540 million, and adjusted diluted EPS of $1.34 to $1.39. The company also said it ended the quarter with a record funded backlog of $5.1 billion, up 17% year over year, and a book-to-bill ratio of 1.2x.

That is the operating picture you want to keep in view before you get lost in the filing. A defense electronics supplier with a growing backlog and raised guidance is not trading on hope alone. It is trading on the market’s willingness to pay for visibility, and on the belief that the current spending cycle will keep feeding orders into the next few quarters.

The stock has not been behaving as if that story is new. DRS traded around $36.57 to $37 in early September 2026, down from a 52-week high of $50.59 and off roughly 17% to 19% over the month cited in the grounded research. That is a real reset. It is also the kind of reset that can make a routine insider sale look more interesting than it is, because the stock is no longer sitting near the top of the range where every disposal feels like a victory lap.

The peer group helps frame that. Lockheed has been able to raise guidance on missile and F-35 demand. RTX and General Dynamics continue to show resilient order books. DRS trades at a forward P/E of about 30.6x, below the U.S. aerospace and defense industry average of 37x in the cited valuation data, while peers such as BWX Technologies and Moog sit in the 31x to 41x range. So the stock is not obviously cheap, but it is also not the most expensive thing in the hangar.

Mark Dorfman sold after the stock had already cooled

On September 8, 2026, DRS reported a Form 4 showing Mark Dorfman, EVP, General Counsel and Secretary, sold 7,471 shares on September 4 at $37.01 per share. The filing value was about EUR 237,930, euro-normalised at ingest. Dorfman held 29,271 shares directly afterward, and the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.

That last detail matters. A 10b5-1 plan does not erase the fact of the sale, but it does change the read. This was not a spontaneous exit on a headline or a one-day judgment call. It was scheduled. The market still has to decide whether the timing was convenient, but the filing itself says the trade was pre-set months earlier.

The size is also worth keeping in proportion. InsiderTrades data flags the transaction as a negligible fraction of market value, under 0.01% of the company’s market cap of about EUR 8.84 billion. That is not the kind of disposal that changes the capital structure, and it is not the kind of sale that tells you the business is broken. It is a filing from an operating executive who still owns stock after the trade, in a company whose shares had already come off the highs.

The more interesting point is that Dorfman did not sell alone. The filing sits inside a cluster. That is where the pattern starts to matter more than the single line item.

The cluster is the real context, and it is not subtle

InsiderTrades data classifies the name as part of an insider cluster, with four distinct insiders and nine recent declarations. The recent sequence includes Dorfman selling on September 8 and September 4, CFO Michael Dippold selling 20,317 shares on September 2 at a weighted average $37.18, and Jason Rinsky selling on August 5, August 4 and July 8. Earlier 2026 sales by multiple officers also occurred at higher prices near $45 to $50, according to the grounded research.

That sequence is the part you should actually read. One sale can be housekeeping. A run of sales across several officers over several weeks is a different matter, even when each trade has its own explanation and some sit inside 10b5-1 plans. It tells you that the company’s insiders have been reducing exposure while the stock has been working through a lower range than it saw earlier in the year.

The market does not need to overreact to that. DRS is still a defense name with a strong backlog, and the sector is still supported by procurement and replenishment demand. But the cluster does tell you something about timing. Officers were more willing to sell when the stock was near $45 to $50, and they are still selling now that it is closer to $37. That is not a bullish tell. It is a reminder that the people filing these forms have not been leaning into the pullback with open-market buys.

The company’s fundamental score in the dossier is 48, with a quality score of 57 and a value score of 39. Those are not heroic numbers, and they do not need to be. They fit a business that is solid, not pristine, and a stock that has already been repriced enough to invite debate without making the debate easy.

What the sector is paying for, and why DRS still screens well enough

Defense is not one trade right now. It is a bundle of trades tied together by the same budget logic. Ukraine, the Middle East, NATO commitments, U.S. replenishment, space systems, autonomy, sensors, and industrial capacity all feed the same spending machine. Defense News reported in early September that firms are still benefiting from ample military spending, even as manufacturing constraints test the sector. That is the environment DRS lives in.

The company’s own mix is well suited to it. Tactical radars and infrared sensing are not glamorous in the way a fighter jet is glamorous, but they are exactly the sort of capabilities that get funded when militaries want better detection, targeting and survivability. Electric power and propulsion, naval systems and space-related sensor work give DRS exposure to programs that can stretch over years rather than quarters. That is why backlog matters so much here. The company is not just selling hardware, it is selling visibility.

JPMorgan recently lifted its price target on DRS to $53 from $48, while keeping a Neutral rating, according to the cited stockanalysis coverage. That is a decent summary of the market’s posture. The Street sees enough operational strength to justify a higher target, but not enough obvious mispricing to turn the name into a simple buy. The stock can be good and still not be cheap. It can be expensive and still have room if the backlog keeps converting.

That is where the insider sales become a useful cross-check rather than a thesis. If the business were stalling, the filings would look like confirmation. They do not. If the business were so obviously underpriced that insiders were piling in, the filings would look different too. They do not. What you have instead is a company with decent operating momentum, a rich but not absurd multiple, and a management group that has been trimming stock while the sector remains bid.

What our cohort data actually says about this kind of name

InsiderTrades data gives you one more lens, and it should stay in its lane. The historical cohort for director-level buys at large-cap names shows a 55.6% win rate over 90 days and an average return of 3.25%, with a 365-day average return of 89.18% across 5,370 cases. That is the kind of statistic that can keep you honest about how much weight to put on a filing, especially when the trade in front of you is a sale rather than a buy.

But the bucket is not the trade. The cohort is built around director-level buys, while this filing is a sale by an EVP, General Counsel and Secretary. Different role, different direction, different context. The point is not to force the numbers to say something they do not. The point is to remind you that insider data works best as a pattern read, not as a one-line verdict.

The strategy framework in the dossier is also there if you want the broader system view, but it should stay in the background. The live out-of-sample headline is 0.81, with 26.4 and 51.5 on the same restricted EU venue universe, and those figures come with the usual caveat about a short, single-regime window and search-aware deflation. That is a screen, not an alpha claim. For this name, the more useful question is simpler: does the filing line up with the business and the price action, or does it fight them?

Here, it lines up with the price action more than with the business. The business is still doing fine. The stock has already cooled. The insiders have been selling into that cooler tape, and they have been doing it in a cluster.

The part that can still go wrong from here

The obvious risk is that you read too much into a sale that was pre-arranged months earlier. That would be lazy. Dorfman’s trade was under a Rule 10b5-1 plan adopted on March 6, and the filing itself says so. The market should not pretend that every scheduled sale is a fresh opinion on the quarter.

The other risk is the opposite one, which is more common. You see a strong defense backdrop, a growing backlog, a raised guide and a stock that is down from the highs, and you decide the insider sales do not matter. They do matter, just not in the cartoon way. They tell you that management has been willing to reduce exposure while the stock still trades at a premium multiple and while the company is still executing well enough to keep the Street engaged.

DRS is not a distressed name, and it is not a screaming bargain. It is a defense electronics business with a $5.1 billion funded backlog, a 1.2x book-to-bill ratio, and a share price that has already come in from $50.59 to the high $30s. That combination can support the stock if the next few quarters keep converting backlog into revenue and margin. It can also leave the shares vulnerable if execution slips, because the multiple already assumes a fair amount of competence.

The insider cluster does not change that math on its own. It does, however, tell you where the pressure is coming from. Officers have been selling, not buying, and they have been doing it across several dates and roles. If you are looking for a clean bullish insider tell, this is not it. If you are looking for a way to read the filing against a still-favorable defense cycle, the answer is that the filing is a caution flag, not a thesis breaker.

What to watch when the next filing or quarter lands

The next useful checkpoint is not another abstract sector headline. It is whether DRS keeps turning backlog into revenue at the pace implied by the raised guide, and whether the company can hold the 1.2x book-to-bill rhythm while the defense budget cycle stays supportive. If the next quarter shows the same pattern of organic growth and EBITDA expansion, the stock can keep earning its multiple even after the recent pullback.

The next filing matters too, because the cluster is now part of the story whether you like it or not. If the selling continues, especially if it broadens beyond the current group, the market will have to decide whether that is routine diversification or a more persistent reduction in exposure. If it stops here, the September trades will look more like a run of scheduled disposals into a weaker share price than a broader message.

For now, the useful read is narrow. DRS is a defense electronics name with real backlog, real guidance and a sector tailwind that has not gone away. Mark Dorfman sold 7,471 shares at $37.01, and he did it inside a cluster that already includes the CFO and other officers. The stock is lower than it was, the business is still growing, and the next quarter will tell you whether the market was right to keep paying for that visibility.

Dig deeper: Leonardo DRS, Inc.'s full insider filing history.

This is not investment advice.